New approach to dilation of stenotic lesions through the accessory hepatic vein in Budd-Chiari syndrome  by Sun, Zhanguo et al.
From
H
Auth
Rep
Pe
D
The
to
an
2352
Cop
So
BY
4.
http
42New approach to dilation of stenotic lesions
through the accessory hepatic vein in Budd-Chiari
syndrome
Zhanguo Sun, MD, Jingjun Jiang, MD, Wei Li, PhD, Xuemin Zhang, MD, Xiaoming Zhang, MD, and
Changshun He, PhD, Beijing, China
We investigated a new approach to dilation of stenotic lesions through the femoral vein-accessory hepatic vein-
intrahepatic communicating branched vein-hepatic vein-inferior vena cava loop in two cases of Budd-Chiari syndrome.
For some selected patients, this approach represents an additional method to increase technical success and to decrease
complications. (J Vasc Surg Cases 2015;1:42-5.)The most commonly used approaches for the endovas-
cular treatment of Budd-Chiari syndrome (BCS) are percu-
taneous transhepatic, femoral vein-inferior vena cava
(IVC)-hepatic vein (HV), and jugular vein-IVC-HV. We
report an alternative approach through the femoral vein-
accessory hepatic vein (AHV)-intrahepatic communicating
branched vein-HV-IVC loop in two cases of BCS. Both pa-
tients provided consent to publish this case report.
CASE REPORT
Case 1. A 46-year-old woman complained of abdominal
distention, shortness of breath after exercise, and a 15-year history
of varicose superﬁcial epigastric veins. Physical examination
showed that the ﬂow direction of the varicose superﬁcial epigastric
veins was cephalad. The liver was enlarged, with its lower edge
1 cm below the right costal margin. Ultrasound (US) examination
of the abdomen revealed hepatomegaly and obstruction of the
retrohepatic segment of the IVC. The blood ﬂow was hepatopedal.
No other imaging modalities were used. The preoperative diag-
nosis was BCS, and no concomitant diseases that may have been
risk factors for or causes of the development of BCS were found.
After puncture of the right femoral vein under local anesthesia, a
pigtail catheter was placed in the IVC; angiography showed a long,
obstructive lesion of the hepatic segment of the IVC, AHV
compensatory enlargement, and dilation of the abundant intra-
hepatic communicating branched veins (Fig 1, A). Subsequent
angiography with a pigtail catheter after catheterization of thethe Department of Vascular Surgery, Peking University People’s
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communicating branched vein-HV demonstrated severe stenosis
of the suprahepatic IVC (Fig 1, B). The blood ﬂow of the HV was
static, and the pressure was 25 cm H2O. A 0.035-inch angled hy-
drophilic guidewire was passed through the stenosis of the supra-
hepatic IVC, and the lesion was subjected to balloon angioplasty
(diameters of 8 mm and 14 mm successively) (Fig 1, C and D).
Repeated angiography showed 0% residual stenosis (Fig 1, E). The
blood ﬂow to the heart through the HV returned to normal
(Fig 1, F), and the pressure in the HV decreased to 14 cm H2O.
After the procedure, the varicose superﬁcial epigastric vein was no
longer visualized, and the liver was shown to have decreased in size
on abdominal US. Warfarin was used for long-term anti-
coagulation. The patient was observed with US examination at
3 months, 6 months, and 12 months after the operation and yearly
thereafter. The US examination 3 months after the procedure
showed a normal-size liver and patency of the suprahepatic IVC.
Case 2. A 28-year-old man complained of a 1-year history of
abdominal distention. No concomitant diseases that may have
been risk factors for or causes of the development of BCS were
found. Varicose superﬁcial veins were visible in the midsection, and
the ﬂow direction was cephalad. The liver was enlarged, with its
lower edge 3 cm below the right costal margin. Physical exami-
nation revealed pitting edema of the lower extremities. Abdominal
US revealed hepatomegaly and obstruction of both the HV and
the retrohepatic segment of the IVC. The blood ﬂow was hep-
atofugal. No other imaging modalities were used. Angiography
after puncture of the right femoral vein under local anesthesia
revealed severe stenosis of the IVC and stenosis of the opening of
the AHV (Fig 2, A). Subsequent angiography after catheterization
of the AHV with a JR4 catheter revealed dilation of the abundant
intrahepatic communicating branched veins, stasis of the HV, and
obstruction at the junction of the right HV and the IVC (Fig 2, B).
The pressure in the HV was 27 cm H2O. A 0.035-inch angled
hydrophilic guidewire was passed through the occlusive segment of
the HV to the suprahepatic IVC by the new approach under the
support of a 55-cm-long 6F introducer sheath. The lesions of the
AHV and the right HV were free from residual stenosis after
balloon angioplasty (10 mm in diameter) (Fig 2, C-E). Angioplasty
of the stenosed IVC was then performed with a 25-mm balloon,
and the stenosis was subsequently resolved (Fig 2, F). The pressure
Fig 1. A, Long obstructive lesion of the hepatic segment of the inferior vena cava (IVC), accessory hepatic vein (AHV)
compensatory enlargement, and dilation of the abundant intrahepatic communicating branched veins. B, Severe stenosis
of the IVC. C and D, The lesion was subjected to balloon angioplasty (diameters of 8 mm and 14 mm successively). E,
The stenosis had disappeared. F, The blood ﬂow to the heart through the hepatic vein (HV) returned to normal.
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extremity edema also resolved within 1 week. Warfarin was used
for long-term anticoagulation. The follow-up plan was the same as
in the ﬁrst case. The US examination 12 months after the proce-
dure showed a normal-size liver and patency of the HV and the
suprahepatic IVC.
DISCUSSION
BCS is deﬁned as hepatic venous outﬂow obstruction
at any level from the small HVs to the junction of the
IVC and the right atrium.1 The goal of therapy is to relieve
hepatic venous outﬂow tract obstruction. Treatments of
BCS include radical resection of lesions, liver transplanta-
tion, surgical shunts, and endovascular techniques
including angioplasty with or without stent placement.
Open surgeries that were previously used as a standard
treatment always have a high mortality rate.2 Endovascular
treatment, with its minimally invasive and reproducible fea-
tures, can shorten the hospital stay and reduce the mortal-
ity rate.3-5 It has become the primary treatment of choice
for BCS, especially for those with short-length HV or
IVC stenosis or occlusion.6 The Achilles heel of endovascu-
lar treatment is the high rate of restenosis.7The AHV was ﬁrst observed by Elias and Petty in
1952.8 The angle between the AHV and the IVC is
approximately 90 degrees.9 In patients with BCS, the
abundant intrahepatic communicating branched veins
dilate (because of HV stenosis or occlusion), and the
AHV compensates for hepatic venous drainage. At this
time, signs and symptoms of posthepatic portal hyperten-
sion may not appear. Catheterization of the HV through
the femoral vein-IVC route is usually difﬁcult because of
the acute angle between the HV and IVC. Catheterization
of the HV through the jugular vein-IVC route can usually
be attained, but internal jugular vein puncture subjects the
patient to the risk of carotid artery injury or hemothorax or
pneumothorax. Percutaneous transhepatic access is techni-
cally difﬁcult, and the incidence of complications such as
HV thrombosis, biliary tract injuries, and hemorrhage is
high.10 Catheterization of the AHV is more easily achieved
than catheterization of the HV because of the larger angle
between the AHV and the IVC. The abundant intrahepatic
communicating branched veins often dilate in BCS because
of the peripheral HV stenosis or occlusion, thereby allow-
ing easier access and cannulation of the HV (Fig 3). Be-
tween June 2001 and December 2013, 236 patients with
Fig 2. A, Severe stenosis of the inferior vena cava (IVC) and stenosis of the opening of the accessory hepatic vein (AHV).
B,Obstruction at the junction of the right hepatic vein (HV) and the IVC.C andD, Angioplasty with a balloon 10 mm in
diameter. E, The stenosis of the HV had disappeared. F, The stenosis of the IVC had disappeared.
Fig 3. The schematic drawing of this new approach. AHV,
Accessory hepatic vein; FV, femoral vein; HV, hepatic vein; IVC,
inferior vena cava.
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accounted for 18% of the cases. Combined IVC and HV
occlusion accounted for 67% of the cases, whereas 15% of
the patients had pure IVC occlusion. Of these patients,
106 were treated by radical resection surgery, 119 were
treated by angioplasty with or without stent placement, 7
were treated with thrombolysis, and 4 were treated with
surgical shunts. In addition to these two patients, we un-
successfully attempted this approach in three other patients
and thought that we failed because the occluded segment
of the HV or IVC was too long. We believe that the
approach described in this report is likely to be successful
for short-segment stenosis or occlusion of the HV or supra-
hepatic IVC. To the best of our knowledge, this is the ﬁrst
report describing the femoral vein-AHV-intrahepatic
communicating branched vein-HV-IVC loop approach.
CONCLUSIONS
Catheterization of the AHV, intrahepatic communi-
cating branches, and HV to reach the IVC is a new and
novel approach in the endovascular treatment of BCS
and can be used in selected patients.REFERENCES
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